Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis

ObjectiveTo evaluate whether transcatheter or surgical aortic valve replacement (TAVR or SAVR) affects clinical and haemodynamic outcomes in symptomatic patients with moderately-severe aortic stenosis (AS).MethodsEchocardiographic evidence of severe AS for enrolment in the Evolut Low Risk trial was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open heart 2023-05, Vol.10 (1), p.e002297
Hauptverfasser: Ito, Saki, Laham, Roger, Nkomo, Vuyisile T, Forrest, John K, Reardon, Michael J, Little, Stephen H, Mumtaz, Mubashir, Gada, Hemal, Bajwa, Tanvir, Langholz, David, Heiser, John, Chawla, Atul, Jenson, Bart, Attizanni, Guilherme, Markowitz, Alan H, Huang, Jian, Oh, Jae K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ObjectiveTo evaluate whether transcatheter or surgical aortic valve replacement (TAVR or SAVR) affects clinical and haemodynamic outcomes in symptomatic patients with moderately-severe aortic stenosis (AS).MethodsEchocardiographic evidence of severe AS for enrolment in the Evolut Low Risk trial was based on site-reported measurements. For this post hoc analysis, core laboratory measurements identified patients with symptomatic moderately-severe AS (1.0
ISSN:2053-3624
2398-595X
2053-3624
DOI:10.1136/openhrt-2023-002297